Novel genetic targets in endometrial cancer

Bibliography

• Dedes KJ, Wetterskog D, Ashworth A, et al. Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol 2011;8:261-71
   PubMed Web of Science ®Google Scholar
• Kuhn E, Wu RC, Guan B, et al. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. J Natl Cancer Inst 2012;104:1503-13
   PubMed Web of Science ®Google Scholar
• Le Gallo M, O'Hara AJ, Rudd ML, et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat Genet 2012;44:1310-15
   PubMed Web of Science ®Google Scholar
• Zhao S, Choi M, Overton JD, et al. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Proc Natl Acad Sci USA 2013;110:2916-21
   PubMed Web of Science ®Google Scholar
• Liang H, Cheung LW, Li J, et al. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res 2012;22:2120-9
   PubMed Web of Science ®Google Scholar
• Kinde I, Bettegowda C, Wang Y, et al. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci Transl Med 2013;5:167ra4
   PubMed Web of Science ®Google Scholar
• Kandoth C, Schultz N, Cherniack AD, et al. Integrated genomic characterization of endometrial carcinoma. Nature 2013;497:67-73
   PubMed Web of Science ®Google Scholar
• Lee BK, Iyer VR. Genome-wide studies of CCCTC-binding factor (CTCF) and cohesin provide insight into chromatin structure and regulation. J Biol Chem 2012;287:30906-13
   Google Scholar
• Zighelboim I, Mutch DG, Knapp A, et al. High frequency strand slippage mutations in CTCF in MSI-positive endometrial cancers. Hum Mutat 2014;35:63-5
   PubMed Web of Science ®Google Scholar
• Sun X, Frierson HF, Chen C, et al. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet 2005;37:407-12
   PubMed Web of Science ®Google Scholar
• Sinner D, Kordich JJ, Spence JR, et al. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 2007;27:7802-15
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sicot G, Cui X, et al. Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide. Biochemistry 2011;50:10431-41
   PubMed Web of Science ®Google Scholar
• O'Shaughnessy A, Hendrich B. CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now. Biochem Soc Trans 2013;41:777-82
   Google Scholar
• Baba A, Ohtake F, Okuno Y, et al. PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B. Nat Cell Biol 2011;13:668-75
   Google Scholar
• Inuzuka H, Fukushima H, Shaik S, et al. Mcl-1 ubiquitination and destruction. Oncotarget 2011;2:239-44
   PubMed Web of Science ®Google Scholar
• Garnett MJ, Edelman EJ, Heidorn SJ, et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012;483:570-5
   PubMed Web of Science ®Google Scholar
• Rao S, Lee SY, Gutierrez A, et al. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood 2012;120:3764-73
   PubMed Web of Science ®Google Scholar
• Novetsky AP, Zighelboim I, Thompson DM Jr, et al. Frequent mutations in the RPL22 gene and its clinical and functional implications. Gynecol Oncol 2013;128:470-4
   PubMed Web of Science ®Google Scholar
• Heinrich B, Zhang Z, Raitskin O, et al. Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC(A/C)-rich regions in pre-mRNA. J Biol Chem 2009;284:14303-15
   PubMed Web of Science ®Google Scholar
• Adamson B, Smogorzewska A, Sigoillot FD, et al. A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. Nat Cell Biol 2012;14:318-28
   PubMed Web of Science ®Google Scholar
• Matsunaga S, Takata H, Morimoto A, et al. RBMX: a regulator for maintenance and centromeric protection of sister chromatid cohesion. Cell Rep 2012;1:299-308
   PubMed Web of Science ®Google Scholar
• Mihailovich M, Militti C, Gabaldon T, et al. Eukaryotic cold shock domain proteins: highly versatile regulators of gene expression. Bioessays 2010;32:109-18
   PubMed Web of Science ®Google Scholar
• Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N(6)-adenosine methylation. Nat Chem Biol 2014;10:93-5
   PubMed Web of Science ®Google Scholar
• Chen D, Li Z, Yang Q, et al. Identification of a nuclear protein that promotes NF-kappaB activation. Biochem Biophys Res Commun 2003;310:720-4
   PubMed Web of Science ®Google Scholar
• Pajerowski AG, Nguyen C, Aghajanian H, et al. NKAP is a transcriptional repressor of notch signaling and is required for T cell development. Immunity 2009;30:696-707
   PubMed Web of Science ®Google Scholar
• Burgute BD, Peche VS, Steckelberg AL, et al. NKAP is a novel RS-related protein that interacts with RNA and RNA binding proteins. Nucleic Acids Res 2014;42:3177-93
   PubMed Web of Science ®Google Scholar
• Giovannone B, Lee E, Laviola L, et al. Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling. J Biol Chem 2003;278:31564-73
   PubMed Web of Science ®Google Scholar
• Morita M, Ler LW, Fabian MR, et al. A novel 4EHP-GIGYF2 translational repressor complex is essential for mammalian development. Mol Cell Biol 2012;32:3585-93
   PubMed Web of Science ®Google Scholar
• Lee TH, Wisniewski HG, Vilcek J. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J Cell Biol 1992;116:545-57
   PubMed Web of Science ®Google Scholar
• Milner CM, Higman VA, Day AJ. TSG-6: a pluripotent inflammatory mediator? Biochem Soc Trans 2006;34(Pt 3):446-50
   PubMed Web of Science ®Google Scholar
• Lang F, Voelkl J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opin Investig Drugs 2013;22:701-14
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012;2:401-4
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013;6:pl1
   PubMed Web of Science ®Google Scholar